Jee Young Kwon
Overview
Explore the profile of Jee Young Kwon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
851
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hallast P, Ebert P, Loftus M, Yilmaz F, Audano P, Logsdon G, et al.
Nature
. 2023 Aug;
621(7978):355-364.
PMID: 37612510
The prevalence of highly repetitive sequences within the human Y chromosome has prevented its complete assembly to date and led to its systematic omission from genomic analyses. Here we present...
2.
Kwon J, Moskwa N, Kang W, Fan T, Lee C
J Breast Cancer
. 2023 Feb;
26(1):1-13.
PMID: 36762784
Despite the advances in research and treatment of human breast cancer, its incidence rate continues to increase by 0.5% per year, and the discovery of novel therapeutic strategies for specific...
3.
Kim G, Yoon Y, Park J, Won Park J, Noh M, Kim H, et al.
Microbiome
. 2022 Nov;
10(1):188.
PMID: 36333752
Background: Comparisons of the gut microbiome of lean and obese humans have revealed that obesity is associated with the gut microbiome plus changes in numerous environmental factors, including high-fat diet...
4.
Jang G, Oh J, Jun E, Lee J, Kwon J, Kim J, et al.
NPJ Genom Med
. 2022 Oct;
7(1):63.
PMID: 36302783
Pancreatic cancer exhibits a characteristic tumor microenvironment (TME) due to enhanced fibrosis and hypoxia and is particularly resistant to conventional chemotherapy. However, the molecular mechanisms underlying TME-associated treatment resistance in...
5.
Ning G, Zhu Q, Kang W, Lee H, Maher L, Suh Y, et al.
BMC Cancer
. 2021 Aug;
21(1):923.
PMID: 34399705
Background: Gastric cancer (GC) is one of the leading causes of cancer-related deaths worldwide. Human epidermal growth factor receptor 2 (HER2) amplification occurs in approximately 13-23% of all GC cases...
6.
Kim G, Kim M, Kim M, Park C, Yoon Y, Lim D, et al.
Commun Biol
. 2021 Feb;
4(1):231.
PMID: 33608630
An unbalanced microbial ecosystem on the human skin is closely related to skin diseases and has been associated with inflammation and immune responses. However, little is known about the role...
7.
Lee S, Cho S, Yoon Y, Park C, Sohn J, Jeong J, et al.
Nat Microbiol
. 2021 Jan;
6(3):277-288.
PMID: 33432149
The gut microbiome can influence the development of tumours and the efficacy of cancer therapeutics; however, the multi-omics characteristics of antitumour bacterial strains have not been fully elucidated. In this...
8.
Lee J, Choi A, Cho S, Jun Y, Na D, Lee A, et al.
Mol Oncol
. 2020 Nov;
15(2):487-502.
PMID: 33188726
Erlotinib is highly effective in lung cancer patients with epidermal growth factor receptor (EGFR) mutations. However, despite initial favorable responses, most patients rapidly develop resistance to erlotinib soon after the...
9.
Chaisson M, Sanders A, Zhao X, Malhotra A, Porubsky D, Rausch T, et al.
Nat Commun
. 2019 Apr;
10(1):1784.
PMID: 30992455
The incomplete identification of structural variants (SVs) from whole-genome sequencing data limits studies of human genetic diversity and disease association. Here, we apply a suite of long-read, short-read, strand-specific sequencing...
10.
Kim H, Kim S, Kwon J, Kim Y, Kang S, Jang W, et al.
PLoS One
. 2017 Mar;
12(3):e0174460.
PMID: 28319172
[This corrects the article DOI: 10.1371/journal.pone.0166044.].